WHO Adds Interleukin-6 Receptor Blockers to COVID-19 Treatment List
Individuals who become gravely ill with COVID-19 often experience an overzealous immune response, worsening their condition. The use of interleukin-6 receptor blockers, such as tocilizumab and sarilumab, can quell this overreaction,…